All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as …

November 14-19, 2024. Washington, DC. “How Quickly Will I Feel Better with This New Drug?” – Rapidity of Treatment Response in Patients with Axial Spondyloarthritis Treated with Bimekizumab: …

About ACR Convergence College of Rheumatology, is where rheumatology meets to collaborate, celebrate, congregate, and learn. With hundreds of sessions and thousands of abstracts, it offers a …

Download Abstracts ACR Convergence 2025 Abstract Supplement (PDF) – 134mb ACR Convergence 2024 Abstract Supplement (PDF) – 188mb ACR Convergence 2023 Abstract Supplement (PDF) – …

EMBARGO LIFTS: Thursday, Nov. 14 at 10:00 a.m. ET Media Contact: Monica McDonald Office: (404) 365-2162 Email: mmcdonald@rheumatology.org

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as …

Date: Saturday, November 16, 2024 Time: 9:15AM-10:45AM Meeting: ACR Convergence 2024 9:15AM-10:45AM Abstract Number: 0774 A Multicenter, Randomized, Controlled Trial to Evaluate the Effects …

Impact of Peripheral Manifestations on Function, Health, and Work Productivity in Patients with Axial Spondyloarthritis, Peripheral Spondyloarthritis and Psoriatic Arthritis.

Nov 16, 2024 · Below is a collection of the industry press releases detailing the abstracts, authors and presentation times from ACR 2024. You can search the ACR site for these abstract numbers here.

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as …